A hairy kinase

نویسنده

  • Nicole LeBrasseur
چکیده

A hairy kinase o get a hairy mouse, look to the Sgk3 kinase. So say Alonso et al. on page 559. The control of hair follicle growth has been an enigma for cell biologists. While growth factors such as EGF are known for their ability to stimulate proliferation in epithelial cells, EGF causes hair loss. In addition, the downstream signals that control hair growth are largely unknown. Now, an Akt relative called Sgk3 is identified as a hair growth kinase. Similar to EGF treatment, loss of Sgk3 in mice results in short, thin hair coats due to problems in follicle growth. The engine for hair production is the hair bulb, which is composed of epithelial matrix cells at the follicle base. These cells, derived from follicle stem cells, differentiate to produce the hair. Throughout normal adult life, hair follicles undergo cycles of growth and shrinkage. In the sgk3 mutant, the shrinking phase begins prematurely, before the hair has fully developed. Alonso et al. find that apoptosis, cell cycling, and differentiation timing are all roughly normal in the sgk3 mutant matrix. Recruitment of progenitors into the matrix, however, seems to be impaired, thus accelerating the exhaustion of the matrix cell supply and initiation of shrinkage. The question now is which compartment uses the kinase to control the maintenance of the matrix. It might be the matrix itself, the stem cell niche, or the outer root sheath connecting the two compartments. T

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Black Hairy Tongue Associated with Erlotinib Treatment in a Patient with Advanced Lung Cancer

Erlotinib is a tyrosine kinase inhibitor that acts on the epidermal growth factor receptor (EGFR). There have been many reports of the mucocutaneous side effects related to several EGFR inhibitors (EGFRIs). However, no case of black hairy tongue (BHT) associated with EGFRI has been reported. Herein, we report the first case of erlotinib-induced BHT in a 61-year-old man with advanced lung cancer...

متن کامل

Removing a hair of doubt about BRAF targeting.

In this issue of Blood, Pettirossi et al, including Drs Tiacci and Falini, who led the effort in 2011 defining the BRAF-V600E driving mutation in hairy cell leukemia (HCL),provide extensive laboratory studies showing that inhibitors of BRAF-V600E and/or mitogen-activated protein kinase kinase (MEK) reach their targets and cause HCL cell death

متن کامل

An extremely rare case of concurrent BRAF V600E mutation driven hairy cell leukemia and melanoma: case report and review of literature

BRAF protein is a serine/threonine kinase with 766 amino acids. Approximately 15% of human cancers harbor BRAF mutations as well as other BRAF anomalies (amplifications, fusions). Somatic mutations mainly occur in the catalytic kinase domain (CR3), and the predominant mutation is p.V600E which is the substitution of glutamic acid (E) for valine (V) as result of a mutation at codon 600 of the ki...

متن کامل

CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras and junD.

Hairy cell leukemia (HCL) is a chronic lymphoproliferative disease, the cause of which is unknown. Diagnostic of HCL is abnormal expression of the gene that encodes the beta2 integrin CD11c. In order to determine the cause of CD11c gene expression in HCL the CD11c gene promoter was characterized. Transfection of the CD11c promoter linked to a luciferase reporter gene indicated that it is suffic...

متن کامل

BRAF inhibitor: targeted therapy in hairy cell leukemia.

In this issue of Blood, Dietrich et al report that the low-dose BRAF inhibitor, vemurafenib, is highly effective in refractory hairy cell leukemia. Despite enormous progress that has been made with purine nucleoside analogs as the initial treatment of patients with hairy cell leukemia, the relapse rate and eventual development of refractory disease mandate the continued search for effective new...

متن کامل

BRAF Mutation in Hairy Cell Leukemia

BRAF is a serine/threonine kinase with a regulatory role in the mitogen-activated protein kinase (MAPK) signaling pathway. A mutation in the RAF gene, especially in BRAF protein, leads to an increased stimulation of this cascade, causing uncontrolled cell division and development of malignancy. Several mutations have been observed in the gene coding for this protein in a variety of human malign...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The Journal of Cell Biology

دوره 170  شماره 

صفحات  -

تاریخ انتشار 2005